Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/1999
08/12/1999WO1999039712A1 Substituted semicarbazides and the use thereof
08/12/1999WO1999039702A2 Method for regulating size and growth of vascularized normal tissue
08/12/1999WO1999039647A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999WO1999028304A3 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
08/12/1999WO1999026606A3 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS
08/12/1999WO1999020291A9 Pharmaceutical grade ginkgo biloba
08/12/1999WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
08/12/1999WO1996037199A8 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
08/12/1999CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999CA2320625A1 45 human secreted proteins
08/12/1999CA2320300A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999CA2319693A1 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
08/12/1999CA2319664A1 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
08/12/1999CA2319555A1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/12/1999CA2319494A1 5-membered heterocyclic condensed benzoderivatives, the preparation thereof and their use as pharmaceuticals
08/12/1999CA2319484A1 Substituted semicarbazides and the use thereof
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/11/1999EP0935000A2 Orphan receptor
08/11/1999EP0934937A1 Azole derivatives as superoxide radical inhibitor
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934928A1 Cyclic amine derivatives
08/11/1999EP0934422A2 Gene therapy for congestive heart failure
08/11/1999EP0934410A1 Brain-associated inhibitor of tissue-type plasminogen activator
08/11/1999EP0934404A1 Inhibition of proliferation of cells
08/11/1999EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
08/11/1999EP0934337A1 A process for purifying apolipoprotein a or apolipoprotein e from human plasma
08/11/1999EP0934336A1 Novel compounds
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934331A2 Mirror-symmetrical selection and evolution of nucleic acids
08/11/1999EP0934326A1 Substituted aminoalkane phosphonic acids
08/11/1999EP0934321A1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/11/1999EP0934311A2 New heterocyclylmethyl-substituted pyrazol derivates
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934305A1 Integrin antagonists
08/11/1999EP0934301A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934288A1 Oxadiazoles, processes for their preparation and their use as medicaments
08/11/1999EP0934286A1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
08/11/1999EP0934273A1 New derivates from piperidine-keto acid, their preparation and use
08/11/1999EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934257A1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones
08/11/1999EP0934068A1 Compounds and methods
08/11/1999EP0933995A1 Method of treating endothelial injury
08/11/1999EP0781282B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
08/11/1999EP0666741B1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases
08/11/1999EP0646132B1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
08/11/1999CN1225654A Angiogenic inhibitory compounds
08/11/1999CN1225639A Phosphinate based inhibitors of matrix metalloproteases
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/11/1999CN1225631A Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide
08/11/1999CN1225624A Inhibition of matrix metalloproteases by substituted phenethyl compounds
08/11/1999CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds
08/11/1999CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
08/11/1999CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease
08/11/1999CN1225362A Indole derivatives
08/11/1999CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/11/1999CN1225273A Health-care traditional Chinese medicine, and method for preparing same
08/11/1999CN1225265A Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same
08/10/1999US5936084 Halo-substituted bisindolemaleimide protein kinase C inhibitors
08/10/1999US5935985 Phenoxyacetic acid derivatives
08/10/1999US5935984 Heterocyclically substituted phenylglycinolamides
08/10/1999US5935983 For treatment of restenosis
08/10/1999US5935973 Affinity for 5-ht1a, alpha1, alpha2 and/or d2 receptors; antidepressants, anxiolytic agents, psychoses, dyskinesias, parkinson's disease, hypotensive agents, tourette's syndrome, obsessive-compulsive behaviour, panic attacks, social phobias
08/10/1999US5935970 Treatment of nerve system disorders, neurodegenerative diseases
08/10/1999US5935945 Methods of treating or preventing cardiac arrhythmia
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935930 Antithrombotic materials and methods
08/10/1999US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas
08/10/1999US5935924 Administering an effective dosage of growth hormone or a mixture ofgrowth hormone and angiotensin-converting enzyme inhibitor to mammals
08/10/1999US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo.
08/10/1999US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase.
08/10/1999US5935820 Polynucleotides encoding vascular endothelial growth factor 2
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935585 Novel compounds useful in topical and systemic treatment of dermatological conditions associated with a keratinization disorder, and inflammatory or immunoallergenic component; body and hair care cosmetics
08/10/1999CA2260698A1 Pyrrolidine and piperidine derivatives
08/10/1999CA2011144C Nicotinic acid derivatives and pharmaceutical compositions comprising same
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999038998A1 Methods of identifying modulators of kinases responsive to stress
08/05/1999WO1999038983A1 Novel sphingosine-1 phosphate lyase
08/05/1999WO1999038873A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038868A1 Azolo triazines and pyrimidines
08/05/1999WO1999038863A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
08/05/1999WO1999038862A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
08/05/1999WO1999038854A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999WO1999038850A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038827A1 PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038518A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
08/05/1999WO1999038510A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999WO1999038492A1 Nasal solutions
08/05/1999WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51
08/05/1999WO1999024398A3 Urea derivatives and their use as integrin inhibitors
08/05/1999WO1999022722A3 Use of macrolides for the treatment of cancer and macular degeneration
08/05/1999WO1999022721A3 Unsubstituted polydiallylamine for treating hypercholesterolemia
08/05/1999WO1999000128A9 Antithrombotic agents
08/05/1999WO1997010824A8 Use of 5ht1b receptor antagonist for the treatment of vascular disease
1 ... 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 ... 1595